CYTOPHAGE TECHNOLOGIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.38 CAD | -2.56% |
|
-2.56% | -46.07% |
| 27/05 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
| 30/04 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.49Cr | - | - | - | - | - | |
| 82TCr | ||||||
| 35TCr | - | - | - | - | ||
| 31TCr | ||||||
| 30TCr | ||||||
| 24TCr |
